Skip to main content
Top
Published in: International Urology and Nephrology 7/2019

01-07-2019 | Urolithiasis | Urology - Original Paper

Twenty-four-hour urine osmolality as a representative index of adequate hydration and a predictor of recurrence in patients with urolithiasis

Authors: Ho Won Kang, Sung Pil Seo, Yun-Sok Ha, Won Tae Kim, Yong-June Kim, Seok-Joong Yun, Wun-Jae Kim, Sang-Cheol Lee

Published in: International Urology and Nephrology | Issue 7/2019

Login to get access

Abstract

Purpose

To determine the value of 24-h urine osmolality (UOsm) as a representative index of adequate hydration and predictor of stone recurrence in patients with urolithiasis.

Methods

Medical records of consecutive patients presenting with renal or ureteric stones between 1994 and 2017 were retrospectively reviewed. Patients were grouped according to the results of 24-h UOsm (low ≤ 564 mOsm/kg H2O, high > 564 mOsm/kg H2O). Metabolic parameters and risk of stone recurrence were compared between the two groups.

Results

The low urine concentration group were more likely to be older, to be female, and to have a lower body mass index and higher glomerular filtration rate than the high concentration group (each P < 0.005). A positive correlation was seen between 24-h UOsm and urinary calcium, sodium, uric acid, and magnesium excretion and 24-h specific gravity; a negative correlation was seen with 24-h urine volume. Stone-forming constituents, such as calcium and uric acid, were significantly higher in the high urine concentration group. Kaplan–Meier estimates showed that the low urine concentration group had a significantly longer stone recurrence-free period than the high urine concentration group (log-rank test, P < 0.001). In multivariate Cox regression analyses, 24-h UOsm was seen to be an independent risk factor for stone recurrence.

Conclusions

UOsm is a promising approach to assessing hydration and predicting stone recurrence in patients with urolithiasis. Maintaining UOsm < 564 mOsm/kg H2O may reduce the risk of stone recurrence.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324CrossRefPubMed Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324CrossRefPubMed
3.
go back to reference Kang HW, Seo SP, Ha Y-S, Kim WT, Kim Y-J, Yun SJ, Kim W-J, Lee S-C (2017) Chronological trends in clinical and urinary metabolic features over 20 years in Korean urolithiasis patients. J Korean Med Sci 32(9):1496–1501CrossRefPubMedPubMedCentral Kang HW, Seo SP, Ha Y-S, Kim WT, Kim Y-J, Yun SJ, Kim W-J, Lee S-C (2017) Chronological trends in clinical and urinary metabolic features over 20 years in Korean urolithiasis patients. J Korean Med Sci 32(9):1496–1501CrossRefPubMedPubMedCentral
4.
go back to reference Siener R, Laube N, Strohmaier W (2011) Recurrence prevention of urolithiasis with respect to economic aspects. Urologe A 50(10):1276, 1278–1282CrossRefPubMed Siener R, Laube N, Strohmaier W (2011) Recurrence prevention of urolithiasis with respect to economic aspects. Urologe A 50(10):1276, 1278–1282CrossRefPubMed
5.
go back to reference Tiselius H-G, Daudon M, Thomas K, Seitz C (2017) Metabolic work-up of patients with urolithiasis: indications and diagnostic algorithm. Eur Urol Focus 3(1):62–71CrossRefPubMed Tiselius H-G, Daudon M, Thomas K, Seitz C (2017) Metabolic work-up of patients with urolithiasis: indications and diagnostic algorithm. Eur Urol Focus 3(1):62–71CrossRefPubMed
6.
7.
go back to reference Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C (2015) Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol 67(4):750–763CrossRefPubMed Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C (2015) Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol 67(4):750–763CrossRefPubMed
8.
go back to reference Fisang C, Anding R, Müller SC, Latz S, Laube N (2015) Urolithiasis—an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Deutsch Arztebl Int 112(6):83 Fisang C, Anding R, Müller SC, Latz S, Laube N (2015) Urolithiasis—an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Deutsch Arztebl Int 112(6):83
9.
go back to reference Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, Neisius A, Philip J, Saita A, Shah H (2017) Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol 35(9):1331–1340CrossRefPubMed Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, Neisius A, Philip J, Saita A, Shah H (2017) Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol 35(9):1331–1340CrossRefPubMed
10.
go back to reference Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A (2005) The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol 173(5):1601–1605CrossRefPubMed Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A (2005) The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol 173(5):1601–1605CrossRefPubMed
12.
go back to reference Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Gambaro G, Gelosa M (2015) Dietary treatment of urinary risk factors for renal stone formation: a review of CLU working group. Arch Ital Urol Androl 87(2):105–120CrossRefPubMed Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Gambaro G, Gelosa M (2015) Dietary treatment of urinary risk factors for renal stone formation: a review of CLU working group. Arch Ital Urol Androl 87(2):105–120CrossRefPubMed
13.
go back to reference Ticinesi A, Nouvenne A, Borghi L, Meschi T (2017) Water and other fluids in nephrolithiasis: state of the art and future challenges. Crit Rev Food Sci Nutr 57(5):963–974CrossRefPubMed Ticinesi A, Nouvenne A, Borghi L, Meschi T (2017) Water and other fluids in nephrolithiasis: state of the art and future challenges. Crit Rev Food Sci Nutr 57(5):963–974CrossRefPubMed
14.
go back to reference Mitra P, Pal DK, Das M (2018) Does quality of drinking water matter in kidney stone disease: a study in West Bengal, India. Investig Clin Urol 59(3):158–165CrossRefPubMedPubMedCentral Mitra P, Pal DK, Das M (2018) Does quality of drinking water matter in kidney stone disease: a study in West Bengal, India. Investig Clin Urol 59(3):158–165CrossRefPubMedPubMedCentral
15.
go back to reference Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839–843CrossRefPubMed Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839–843CrossRefPubMed
16.
go back to reference Lotan Y, Daudon M, Bruyère F, Talaska G, Strippoli G, Johnson RJ, Tack I (2013) Impact of fluid intake in the prevention of urinary system diseases: a brief review. Curr Opin Nephrol Hypertens 22:S1–S10CrossRefPubMed Lotan Y, Daudon M, Bruyère F, Talaska G, Strippoli G, Johnson RJ, Tack I (2013) Impact of fluid intake in the prevention of urinary system diseases: a brief review. Curr Opin Nephrol Hypertens 22:S1–S10CrossRefPubMed
17.
18.
go back to reference Lotan Y, Jiménez IB, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten M (2013) Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol 189(3):935–939CrossRefPubMed Lotan Y, Jiménez IB, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten M (2013) Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol 189(3):935–939CrossRefPubMed
19.
go back to reference Cockcroft DW, Gault H (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed Cockcroft DW, Gault H (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed
20.
go back to reference Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2015) Guidelines on urolithiasis. Eur Urol 40:362–371 Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2015) Guidelines on urolithiasis. Eur Urol 40:362–371
22.
go back to reference Perrier E, Rondeau P, Poupin M, Le Bellego L, Armstrong L, Lang F, Stookey J, Tack I, Vergne S, Klein A (2013) Relation between urinary hydration biomarkers and total fluid intake in healthy adults. Eur J Clin Nutr 67(9):939CrossRefPubMedPubMedCentral Perrier E, Rondeau P, Poupin M, Le Bellego L, Armstrong L, Lang F, Stookey J, Tack I, Vergne S, Klein A (2013) Relation between urinary hydration biomarkers and total fluid intake in healthy adults. Eur J Clin Nutr 67(9):939CrossRefPubMedPubMedCentral
23.
go back to reference Perrier E, Vergne S, Klein A, Poupin M, Rondeau P, Le Bellego L, Armstrong LE, Lang F, Stookey J, Tack I (2013) Hydration biomarkers in free-living adults with different levels of habitual fluid consumption. Br J Nutr 109(9):1678–1687CrossRefPubMed Perrier E, Vergne S, Klein A, Poupin M, Rondeau P, Le Bellego L, Armstrong LE, Lang F, Stookey J, Tack I (2013) Hydration biomarkers in free-living adults with different levels of habitual fluid consumption. Br J Nutr 109(9):1678–1687CrossRefPubMed
24.
go back to reference Armstrong LE (2007) Assessing hydration status: the elusive gold standard. J Am Coll Nutr 26(Suppl 5):575S–584SCrossRefPubMed Armstrong LE (2007) Assessing hydration status: the elusive gold standard. J Am Coll Nutr 26(Suppl 5):575S–584SCrossRefPubMed
25.
go back to reference Perrier ET, Buendia-Jimenez I, Vecchio M, Armstrong LE, Tack I, Klein A (2015) Twenty-four-hour urine osmolality as a physiological index of adequate water intake. Dis Markers 2015:231063CrossRefPubMedPubMedCentral Perrier ET, Buendia-Jimenez I, Vecchio M, Armstrong LE, Tack I, Klein A (2015) Twenty-four-hour urine osmolality as a physiological index of adequate water intake. Dis Markers 2015:231063CrossRefPubMedPubMedCentral
26.
go back to reference Cadoff RE, Drach GW, LeBouton J (1988) Specific gravity test strips used in monitoring urine concentrations of urolithiasis patients. J Urol 139(2):323–325CrossRefPubMed Cadoff RE, Drach GW, LeBouton J (1988) Specific gravity test strips used in monitoring urine concentrations of urolithiasis patients. J Urol 139(2):323–325CrossRefPubMed
28.
go back to reference Voinescu GC, Shoemaker M, Moore H, Khanna R, Nolph KD (2002) The relationship between urine osmolality and specific gravity. Am J Med Sci 323(1):39–42CrossRefPubMed Voinescu GC, Shoemaker M, Moore H, Khanna R, Nolph KD (2002) The relationship between urine osmolality and specific gravity. Am J Med Sci 323(1):39–42CrossRefPubMed
29.
go back to reference Chadha V, Garg U, Alon US (2001) Measurement of urinary concentration: a critical appraisal of methodologies. Pediatr Nephrol 16(4):374–382CrossRefPubMed Chadha V, Garg U, Alon US (2001) Measurement of urinary concentration: a critical appraisal of methodologies. Pediatr Nephrol 16(4):374–382CrossRefPubMed
30.
go back to reference Manz F, Wentz A (2003) 24-h hydration status: parameters, epidemiology and recommendations. Eur J Clin Nutr 57(S2):S10CrossRefPubMed Manz F, Wentz A (2003) 24-h hydration status: parameters, epidemiology and recommendations. Eur J Clin Nutr 57(S2):S10CrossRefPubMed
Metadata
Title
Twenty-four-hour urine osmolality as a representative index of adequate hydration and a predictor of recurrence in patients with urolithiasis
Authors
Ho Won Kang
Sung Pil Seo
Yun-Sok Ha
Won Tae Kim
Yong-June Kim
Seok-Joong Yun
Wun-Jae Kim
Sang-Cheol Lee
Publication date
01-07-2019
Publisher
Springer Netherlands
Keyword
Urolithiasis
Published in
International Urology and Nephrology / Issue 7/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02108-2

Other articles of this Issue 7/2019

International Urology and Nephrology 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.